Literature DB >> 24777300

Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries.

Michael G Gaies1, Howard E Jeffries, Robert A Niebler, Sara K Pasquali, Janet E Donohue, Sunkyung Yu, Christine Gall, Tom B Rice, Ravi R Thiagarajan.   

Abstract

OBJECTIVE: To empirically derive the optimal measure of pharmacologic cardiovascular support in infants undergoing cardiac surgery with bypass and to assess the association between this score and clinical outcomes in a multi-institutional cohort.
DESIGN: Prospective, multi-institutional cohort study.
SETTING: Cardiac ICUs at four academic children's hospitals participating in the Pediatric Cardiac Critical Care Consortium during the study period. PATIENTS: Children younger than 1 year at the time of surgery treated postoperatively in the cardiac ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Three hundred ninety-one infants undergoing surgery with bypass were enrolled consecutively from November 2011 to April 2012. Hourly doses of all vasoactive agents were recorded for the first 48 hours after cardiac ICU admission. Multiple derivations of an inotropic score were tested, and maximum vasoactive-inotropic score in the first 24 hours was further analyzed for association with clinical outcomes. The primary composite "poor outcome" variable included at least one of mortality, mechanical circulatory support, cardiac arrest, renal replacement therapy, or neurologic injury. High vasoactive-inotropic score was empirically defined as more than or equal to 20. Multivariable logistic regression was performed controlling for center and patient characteristics. Patients with high vasoactive-inotropic score had significantly greater odds of a poor outcome (odds ratio, 6.5; 95% CI, 2.9-14.6), mortality (odds ratio, 13.2; 95% CI, 3.7-47.6), and prolonged time to first extubation and cardiac ICU length of stay compared with patients with low vasoactive-inotropic score. Stratified analyses by age (neonate vs infant) and surgical complexity (low vs high) showed similar associations with increased morbidity and mortality for patients with high vasoactive-inotropic score.
CONCLUSIONS: Maximum vasoactive-inotropic score calculated in the first 24 hours after cardiac ICU admission was strongly and significantly associated with morbidity and mortality in this multi-institutional cohort of infants undergoing cardiac surgery. Maximum vasoactive-inotropic score more than or equal to 20 predicts an increased likelihood of a poor composite clinical outcome. The findings were consistent in stratified analyses by age and surgical complexity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777300      PMCID: PMC4159673          DOI: 10.1097/PCC.0000000000000153

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  18 in total

1.  Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery.

Authors:  T J Kulik; F W Moler; J M Palmisano; J R Custer; R S Mosca; E L Bove; R H Bartlett
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

2.  Cardiac arrest in infants after congenital heart surgery.

Authors:  J F Rhodes; A D Blaufox; H S Seiden; J D Asnes; R P Gross; J P Rhodes; R B Griepp; A F Rossi
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  Serum lactate level has prognostic significance after pediatric cardiac surgery.

Authors:  Murat Basaran; Kenan Sever; Eylul Kafali; Murat Ugurlucan; Omer Ali Sayin; Turkan Tansel; Ufuk Alpagut; Enver Dayioglu; Ertan Onursal
Journal:  J Cardiothorac Vasc Anesth       Date:  2005-12-01       Impact factor: 2.628

4.  Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

Authors:  G Wernovsky; D Wypij; R A Jonas; J E Mayer; F L Hanley; P R Hickey; A Z Walsh; A C Chang; A R Castañeda; J W Newburger; D L Wessel
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

5.  Preoperative steroid treatment does not improve markers of inflammation after cardiac surgery in neonates: results from a randomized trial.

Authors:  Eric M Graham; Andrew M Atz; Kimberly E McHugh; Ryan J Butts; Nathaniel L Baker; Robert E Stroud; Scott T Reeves; Scott M Bradley; Francis X McGowan; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2013-07-16       Impact factor: 5.209

6.  Effect of two different bypass techniques on the serum troponin-T levels in newborns and children: does pH-Stat provide better protection?

Authors:  Zsolt L Nagy; Mike Collins; Tracy Sharpe; Saeed Mirsadraee; Rafael R Guerrero; John Gibbs; Kevin G Watterson
Journal:  Circulation       Date:  2003-07-21       Impact factor: 29.690

7.  Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.

Authors:  Jack E Zimmerman; Andrew A Kramer; Douglas S McNair; Fern M Malila
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

8.  Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.

Authors:  Tomomi Hasegawa; Naoki Yoshimura; Shigeteru Oka; Yoshio Ootaki; Yoshiya Toyoda; Masahiro Yamaguchi
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

9.  A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group.

Authors:  G T O'Connor; S K Plume; E M Olmstead; J R Morton; C T Maloney; W C Nugent; F Hernandez; R Clough; B J Leavitt; L H Coffin; C A Marrin; D Wennberg; J D Birkmeyer; D C Charlesworth; D J Malenka; H B Quinton; J F Kasper
Journal:  JAMA       Date:  1996-03-20       Impact factor: 56.272

10.  Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass for cardiac surgery: a randomized controlled trial.

Authors:  Colleen E Gruenwald; Brian W McCrindle; Lynn Crawford-Lean; Helen Holtby; Christopher Parshuram; Patricia Massicotte; Glen Van Arsdell
Journal:  J Thorac Cardiovasc Surg       Date:  2008-12       Impact factor: 5.209

View more
  82 in total

1.  Vasoactive Inotropic Score (VIS) as Biomarker of Short-Term Outcomes in Adolescents after Cardiothoracic Surgery.

Authors:  Richard U Garcia; Henry L Walters; Ralph E Delius; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2015-09-30       Impact factor: 1.655

2.  Risk Factors for Recurrent Acute Kidney Injury in Children Who Undergo Multiple Cardiac Surgeries: A Retrospective Analysis.

Authors:  Denise C Hasson; John T Brinton; Ellen Cowherd; Danielle E Soranno; Katja M Gist
Journal:  Pediatr Crit Care Med       Date:  2019-07       Impact factor: 3.624

3.  Influence of the type of congenital heart defects on epithelial lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Manuela Simonato; Aldo Baritussio; Virgilio P Carnielli; Luca Vedovelli; Gianclaudio Falasco; Michele Salvagno; Massimo Padalino; Paola Cogo
Journal:  Pediatr Res       Date:  2018-02-07       Impact factor: 3.756

4.  Preoperative echocardiographic measures of left ventricular mechanics are associated with postoperative vasoactive support in preterm infants undergoing patent ductus arteriosus ligation.

Authors:  Margaret A Gray; Eric M Graham; Andrew M Atz; Scott M Bradley; Minoo N Kavarana; Shahryar M Chowdhury
Journal:  J Thorac Cardiovasc Surg       Date:  2017-07-05       Impact factor: 5.209

5.  Bioactive Oxylipins in Infants and Children With Congenital Heart Disease Undergoing Pediatric Cardiopulmonary Bypass.

Authors:  Nahmah Kim-Campbell; Catherine Gretchen; Vladimir B Ritov; Patrick M Kochanek; Goundappa K Balasubramani; Elizabeth Kenny; Mahesh Sharma; Melita Viegas; Clifton Callaway; Valerian E Kagan; Hülya Bayír
Journal:  Pediatr Crit Care Med       Date:  2020-01       Impact factor: 3.624

6.  Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Randomized Controlled Trial.

Authors:  Eric M Graham; Reneé H Martin; Jason R Buckley; Sinai C Zyblewski; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Marc Hassid; Andrew M Atz
Journal:  J Am Coll Cardiol       Date:  2019-08-06       Impact factor: 24.094

7.  A Novel Model Demonstrates Variation in Risk-Adjusted Mortality Across Pediatric Cardiac ICUs After Surgery.

Authors:  Sarah Tabbutt; Jennifer Schuette; Wenying Zhang; Jeffrey Alten; Janet Donohue; J William Gaynor; Nancy Ghanayem; Jeffrey Jacobs; Sara K Pasquali; Ravi Thiagarajan; Justin B Dimick; Mousumi Banerjee; David Cooper; Michael Gaies
Journal:  Pediatr Crit Care Med       Date:  2019-02       Impact factor: 3.624

8.  Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis.

Authors:  Fran Balamuth; Scott L Weiss; Julie C Fitzgerald; Katie Hayes; Sierra Centkowski; Marianne Chilutti; Robert W Grundmeier; Jane Lavelle; Elizabeth R Alpern
Journal:  Pediatr Crit Care Med       Date:  2016-09       Impact factor: 3.624

9.  Collaborative quality improvement in the cardiac intensive care unit: development of the Paediatric Cardiac Critical Care Consortium (PC4).

Authors:  Michael Gaies; David S Cooper; Sarah Tabbutt; Steven M Schwartz; Nancy Ghanayem; Nikhil K Chanani; John M Costello; Ravi R Thiagarajan; Peter C Laussen; Lara S Shekerdemian; Janet E Donohue; Gina M Willis; J William Gaynor; Jeffrey P Jacobs; Richard G Ohye; John R Charpie; Sara K Pasquali; Mark A Scheurer
Journal:  Cardiol Young       Date:  2014-08-28       Impact factor: 1.093

10.  Characteristics, Risk Factors, and Outcomes of Extracorporeal Membrane Oxygenation Use in Pediatric Cardiac ICUs: A Report From the Pediatric Cardiac Critical Care Consortium Registry.

Authors:  Marissa A Brunetti; J William Gaynor; Lauren B Retzloff; Jessica L Lehrich; Mousumi Banerjee; Venugopal Amula; David Bailly; Darren Klugman; Josh Koch; Javier Lasa; Sara K Pasquali; Michael Gaies
Journal:  Pediatr Crit Care Med       Date:  2018-06       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.